Catalyst Wire Dossier Catalyst Wire Dossier

THR-β therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for THR-β therapy, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial [Phase 2]

See pricing